Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renin-angiotensin blockade and kidney disease.

× No keyword cloud information.

11 in total

Review 1. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.

Authors: Helmy M Siragy; Robert M Carey
Journal: Am J Nephrol Date: 2010-05-18 Impact factor: 3.754

Review 2. Should albuminuria be a focus of antihypertensive therapy goals?

Authors: Radica Z Alicic; Sandeep A Saha; Robert A Short; Katherine R Tuttle
Journal: Curr Hypertens Rep Date: 2009-10 Impact factor: 5.369

Review 3. Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.

Authors: Carlos M Ferrario
Journal: Life Sci Date: 2009-12-01 Impact factor: 5.037

Review 4. Application of direct renin inhibition to chronic kidney disease.

Authors: Christian W Mende
Journal: Cardiovasc Drugs Ther Date: 2010-04 Impact factor: 3.727

5. Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.

Authors: Karen A Griffin; Anil K Bidani
Journal: Hypertension Date: 2008-12-01 Impact factor: 10.190

Review 6. The current state of RAAS blockade in the treatment of hypertension and proteinuria.

Authors: Rigas G Kalaitzidis; George L Bakris
Journal: Curr Cardiol Rep Date: 2009-11 Impact factor: 2.931

7. Aliskiren improves renal morphophysiology and inflammation in Wistar rats with 2K1C renovascular hypertension.

Authors: Priscila G Pereira; Kíssila Rabelo; Jemima F R da Silva; Bianca T Ciambarella; Juliana G C Argento; Ana L R Nascimento; Aline B Vieira; Jorge J de Carvalho
Journal: Histol Histopathol Date: 2019-10-18 Impact factor: 2.303

Review 8. Identification and management of albuminuria in the primary care setting.

Authors: Louis Kuritzky; Robert Toto; Peter Van Buren
Journal: J Clin Hypertens (Greenwich) Date: 2011-02-01 Impact factor: 3.738

9. Common secondary causes of resistant hypertension and rational for treatment.

Authors: Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal: Int J Hypertens Date: 2011-03-02 Impact factor: 2.420

10. The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors: Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal: Int J Mol Sci Date: 2017-09-16 Impact factor: 5.923